期刊文献+

血清降钙素原与C-反应蛋白水平评价美罗培南与头孢他啶对中枢神经系统感染疗效研究 被引量:11

Effect study of application of meropenem and ceftazidime in the treatment of central nervous system infection evaluated by serum procalcitonin and C-reactive protein level
原文传递
导出
摘要 目的探讨应用血清降钙素原(PCT)和C-反应蛋白(CRP)水平评价美罗培南和头孢他啶对中枢神经系统感染疗效,为合理应用抗菌药物提供依据。方法对医院2011年3月-2013年1月收治的90例中枢神经系统革兰阴性杆菌感染患者,采取两种不同的抗菌药物治疗,A组48例患者采用美罗培南治疗,B组42例患者采用头孢他啶治疗,对两组疗效进行分析,同时比较患者血清降钙素原和C-反应蛋白水平的变化,并与30名健康者为对照组进行比较。结果两种抗菌药物对中枢神经系统革兰阴性杆菌感染治疗,A组总有效率为95.84%、B组为80.95%,差异有统计学意义(P<0.05);同时两组患者发病后血清降钙素原和C-反应蛋白水平要显著高于对照组,而经过相同时间治疗后,A组两种指标要显著优于B组,差异有统计学意义(P<0.05);血清降钙素原和C-反应蛋白水平对中枢系统感染诊断具有较高的灵敏度、特异度和准确度。结论中枢神经系统感染患者降钙素原和C-反应蛋白水平可以作为中枢系统感染程度的指标,同时不同抗菌药物对中枢神经系统感染疗效不同而影响降钙素原和C-反应蛋白水平。 OBJECTIVE To investigate the application the level of serum PCT and CRP to evaluate efficacy of meropenem and ceftazidime on the treatment of central nervous system infections so as to provide basis for reasonable use of antibiotics.METHODS The 90 patients with central nervous system infected by gram-negative bacteria in our hospital were collected from Mar.2011 to Jan.2013 and were treated with two different antibiotics.Group A with 48 patients,was treated with meropenem for therapy;group B with 42 patients,was adopted ceftazidime.The efficacy of the two groups were analyzed simultaneously,at the same time,the levels of serum procalcitonin and C-reactive protein were compared,then compared them with 30 normal volunteers,which served as the control group.RESULTS The two antibiotics were different on the effects to central nervous system infected by gram-negative bacteria.The total effective rate was 95.84%in the group A and 80.95%in the group B.The difference was significant(P〈0.05).Meanwhile,the serum procalcitonin and C-reactive protein levels of the two groups were significantly higher than the volunteer group,and after the same time treatment,the indicators in group A was significantly better than group B(P〈0.05).The Serum procalcitonin and C-reactive protein levels had high sensitivity,specificity and accuracy for the diagnosis of central nervous system infections.CONCLUSION The procalcitonin and C-reactive protein levels in patients with central nervous system infections can be used as indicators for central nervous system infections.The different curative effect of antibiotics on central nervous system infections impacts the level of procalcitonin and C-reactive protein.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2015年第4期741-743,共3页 Chinese Journal of Nosocomiology
基金 中华医院感染控制研究基金资助项目(ZHYY-2011-041)
关键词 抗菌药物 中枢神经系统感染 降钙素原 C-反应蛋白 Antibiotics Central nervous system infections Procalcitonin C-reactive protein
  • 相关文献

参考文献6

二级参考文献69

  • 1苏卫东,徐克,瞿尔力,黄育丹,藤碎龙,包曼华.新生儿严重感染血清降钙素原监测的临床意义[J].临床医学,2006,26(4):66-67. 被引量:33
  • 2李伟,李光乾,林忠东.中枢神经系统感染患儿脑脊液补体C_3,C_4和β-2微球蛋白联合检测的诊断意义[J].温州医学院学报,2007,37(3):244-246. 被引量:4
  • 3王亚慧,张桂珍.检测脑脊液β2微球蛋白在小儿脑炎中的临床意义[J].黑龙江医学,2007,31(5):331-332. 被引量:1
  • 4Assicot M,Gendrel D,Carsin H,et al.High serum procalcitonin concentrations in patients with sepsis and infection[J].Lancet,1993,341(8844):515-518.
  • 5Wichmann MW,Inthorn D,Andress HJ,et al.Incidence and mortality of severe sepsis in surgical intensive care patients:the influence of patient gender on disease process and outcome[J].Intensive Care Med,2000,26(2):167-172.
  • 6Maruna P,Nedelnikova K,Gurlich R,et al.Physiology and genetics of procalcitonin[J].Physiol Res,2000,49(Suppl1):S57-S61.
  • 7Simon L,Gauvin F,Amre DK,et al.Serum procalci-tonin and C-reactive protein levels as markers of bacterial infection:a systematic review and meta-analysis[J].Clin Infect Dis,2004,39(2):206-217.
  • 8Delevaux I,Andre M,Colombier M,et al.Can procalci-tonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes[J].Ann Rheum Dis,2003,62(4):337-340.
  • 9Karzai W,Oberhoffer M,Meier-Hellmann A,et al.Procalcitonin-a new indicator of the systemic response to severe infections[J].Infection,1997,25(6):329-334.
  • 10Hatherill M,Tibby SM,Sykes K,et al.Diagnostic markers of infection:comparison of procalcitonin with C reactive protein and leucocyte count[J].Arch Dis Child,1999,81(5):417-421.

共引文献655

同被引文献88

  • 1覃家敏.神经外科开颅手术颅内感染危险因素分析[J].中国实用神经疾病杂志,2013,16(18):59-60. 被引量:5
  • 2Konstantinidis T, Cassimos D, Gioka T, el al. (:an procalcito nin in cerebrospinal fluid be a diagnostic tool for meningitis? [J]. J Clin I,ab Anal, 2015,29(3):169-174.
  • 3Domańska-Pakiea D,Kaczorowska M,Jurkiewicz E,et al.EEG abnormalities preceding the epilepsy onset in tuberous sclerosis complex patients-aprospective study of 5patients[J].Eur J Paediatr Neurol,2014,18(4):458-468.
  • 4Osakwe C,Otte WM,Alo C.Epilepsy prevalence,potential causes and social beliefs in Ebonyi State and Benue State,Nigeria[J].Epilepsy Res,2014,108(2):316-326.
  • 5Helmstaedter C,Aldenkamp AP,Baker GA,et al.Disentangling the relationship between epilepsy and its behavioral comorbidities the need for prospective studies in new-onset epilepsies[J].Epilepsy Behav,2014(31):43-47.
  • 6Connolly AM,Slade R,Uppal P,et al.Caring for children and adolescents with epilepsy:creating an innovative electronic educational resource[J].J Clin Neurosci,2014,21(10):1831-1832.
  • 7Shorvon S.The evolution of epilepsy theory and practice at the National Hospital for the Relief and Cure of Epilepsy,Queen Square between 1860and 1910[J].Epilepsy Behav,2014(31):228-242.
  • 8Wirrell EC,Wong-Kisiel LC,Nickels KC.Seizure outcome after AED failure in pediatric focal epilepsy:impact of underlying etiology[J].Epilepsy Behav,2014(34):20-24.
  • 9Bellon M,Pfeiffer W,Maurici V.Choice and control:how involved are people with epilepsy and their families in the management of theirepilepsy?Results from an Australian survey in the disability sector[J].Epilepsy Behav,2014(37):227-232.
  • 10江莲英,唐渊,魏凯.脑脊液乳酸脱氢酶、C反应蛋白检测对小儿中枢神经系统感染性疾病的鉴别诊断价值[J].中国医师进修杂志,2010,33(9):35-36. 被引量:6

引证文献11

二级引证文献83

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部